Stay updated on Dapagliflozin in Acute Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Acute Heart Failure Clinical Trial page
- Check9 days agoChange DetectedRecruitment status is updated to no longer recruit participants, indicating enrollment has ended. New navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment label was reformatted with the Revision tag updated to v3.6.0.SummaryDifference0.5%

- Check17 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a new version of the study record. This update reflects metadata changes rather than substantive alterations to trial content.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new release. This change reflects metadata rather than substantive content changes.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page's revision label changed from v3.5.2 to v3.5.3, indicating an update to the page's revision metadata. There are no changes to the visible content or functionality.SummaryDifference0.1%

- Check60 days agoChange DetectedThe study status changed from having no results posted to indicating that results have been submitted. This reflects new progress toward making the trial’s outcome data available to the public.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin in Acute Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.